- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02131220
Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction (ERUPTION)
August 4, 2018 updated by: Ge Junbo, Fudan University
A Randomized, Parallel-controlled, Multi-center Study of the Effects of Intracoronary Recombinant HUman Prourokinase or TIrofiban on the Coronary Flow During Primary PCI for the Acute Myocardial InfartiON
The purpose of this study is to determine whether intracoronary selective thrombolysis are more effective than tirofiban on the coronary flow during primary percutaneous coronary intervention for the acute myocardial infarction.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
362
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Department of Cardiology, Zhongshan Hospital, Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ST-segment elevation AMI within 12 hours of symptom onset
Exclusion Criteria:
- Contraindications to thrombolysis or PCI
- Patients administered a fibrinolytic agent before PCI
- Patients enrolled in clinical trials
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prourokinase
Intracoronary bolus infusion of 20mg prourokinase using selective catheter
|
20mg intracoronary bolus infusion using selective catheter during PCI
Other Names:
|
Active Comparator: Tirofiban
Intracoronary tirofiban bolus infusion using selective catheter (10ug/kg)
|
10ug/kg intracoronary bolus infusion using selective catheter during PCI
Other Names:
|
Placebo Comparator: Normal saline
Intracoronary saline bolus infusion using selective catheter (20ml)
|
intracoronary bolus infusion using selective catheter during PCI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Coronary flow using corrected Thrombolysis In Myocardial Infarction Frame Count (cTFC)
Time Frame: At the end of Percutaneous Coronary Intervention procedure
|
At the end of Percutaneous Coronary Intervention procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
ST segment resolution in ECG
Time Frame: 3 hours post PCI procedure
|
3 hours post PCI procedure
|
peak troponin T level
Time Frame: in the 7 days post PCI procedure
|
in the 7 days post PCI procedure
|
plasma N terminal-proBNP levels
Time Frame: 1 and 30 days post PCI procedure
|
1 and 30 days post PCI procedure
|
infarction area confirmed by SPECT
Time Frame: 30 days post PCI
|
30 days post PCI
|
incidence of major adverse cardiac events (MACE) defined as the composite of death, myocardial infarction and target vessel revascularization
Time Frame: 30 days post PCI
|
30 days post PCI
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
TIMI defined total major bleeding
Time Frame: 30 days post PCI
|
30 days post PCI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Junbo Ge, M.D., Department of Cardiology, Zhongshan Hospital, Fudan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2015
Primary Completion (Actual)
August 1, 2017
Study Completion (Actual)
September 1, 2017
Study Registration Dates
First Submitted
May 3, 2014
First Submitted That Met QC Criteria
May 3, 2014
First Posted (Estimate)
May 6, 2014
Study Record Updates
Last Update Posted (Actual)
August 7, 2018
Last Update Submitted That Met QC Criteria
August 4, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Zhongshan 2012-134
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Karolinska InstitutetUppsala University; The Swedish Research CouncilActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionSweden
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; University Hospital of North... and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial InfarctionNorway
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
Clinical Trials on Prourokinase
-
Suzhou Landing PharmaceuticalsCompleted
-
Tasly Biopharmaceuticals Co., Ltd.CompletedAcute Pulmonary EmbolismChina
-
Beijing Tiantan HospitalRecruiting